Economic Analysis - February 8, 2015
European M&A Lagged in 2014
Mergers and acquisitions (M&A) activity lagged in the European biopharmaceutical market in 2014, analysts said. Healthcare investor HBM Partners presented the figures in its annual biotech M&A report. The $500 million European, VC-backed biotechs generated in upfront fees represents a 50 percent drop on 2013 and a 27 percent decrease compared with the mean of the […]
Uncategorized - February 8, 2015
Cutting Some Carbs Eases IBS
A diet that excludes particularly indigestible carbohydrates can provide markedly reduced irritable bowel syndrome (IBS) symptoms, according to a thesis prepared at the Sahlgrenska Academy. In the study, 197 persons with IBS symptoms were asked what they believe is the cause of their symptoms. In all, 84 percent referred to food intolerance – most often […]
Pharma Business - February 6, 2015
AZ Plan Clears First Hurdle
AstraZeneca announced that Cambridge City Council has granted planning permission for the company’s new global research and development center and corporate headquarters in the city. The facility will be located on the Cambridge Biomedical Campus and will be home to approximately 2,000 employees. “We are very pleased with…[the] decision by Cambridge City Council. Work is […]
Acquisition - February 5, 2015
Ginolis, JOT Life Science Merging
Ginolis, a manufacturer of diagnostic disposables, plans to acquire JOT Automation’s Life Science Division, the companies recently announced. The merger is scheduled to take place during the first half of this year. “The transaction is a win-win for both companies’ customers. It enables us to grow even more customer-centric and accelerates our time-to-market in our […]
Drug Development Pharma - February 5, 2015
FDA OKs Novo Growth Drug
The U.S. Food and Drug Administration (FDA) has granted approval of Novo Nordisk’s Norditropin® FlexPro® 30 mg/3.0 mL, a prefilled injection pen for patients with growth hormone-related disorders. The FlexPro® 30 mg/3.0 mL device complements the existing FlexPro® products. “Novo Nordisk is committed to advancing growth hormone delivery devices with patients in mind,” said Eddie Williams, […]
Acquisition - February 5, 2015
AstraZeneca Teams with Box
AstraZeneca is making Box’s cloud content sharing and collaboration platform available to its 51,000 employees across more than 100 countries. The platform will provide secure collaboration company-wide and with external parties, as well as enable mobile access to information. “AstraZeneca’s move to Box follows our deep emphasis on life sciences, which is an important sector […]
